US Patent

US12274751 — Composition and method of the use of colchicine oral liquid

Method of Use · Assigned to Rxomeg Therapeutics LLC · Expires 2036-11-22 · 11y remaining

Vulnerability score 75/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects a composition and method of using oral liquid colchicine formulations.

USPTO Abstract

Oral liquid colchicine formulations are described herein. Methods of using the oral liquid colchicine formulations are also provided.

Drugs covered by this patent

Colcrys (COLCHICINE) · Scilex Pharms

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-2814`	—	Colcrys

Patent Metadata

Patent number: US12274751
Jurisdiction: US
Classification: Method of Use
Expires: 2036-11-22
Drug substance claim: No
Drug product claim: No
Assignee: Rxomeg Therapeutics LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.